Reboxetine and the missing data
This week Beate Wieseler from IQWiG (Institut f ür Qualität und Wirtschaftlichkeit im Gesundheitswesen) tells us how they uncovered data on the antidepressant reboxetine.
Also Angela Thomas and Julia Anderson, haematologists from the Comprehensive Care Haemophilia and Thrombosis Centre, Royal Infirmary of Edinburgh, explain how to investigate a ... (Source: The BMJ Podcast)
Source: The BMJ Podcast - August 28, 2013 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
Reboxetine and the missing data
This week Beate Wieseler from IQWiG (Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen) tells us how they uncovered data on the antidepressant reboxetine.
Also Angela Thomas and Julia Anderson, haematologists from the Comprehensive Care Haemophilia and Thrombosis Centre, Royal Infirmary of Edinburgh, explain how to investigate a child who bruises easily. (Source: The BMJ Podcast)
Source: The BMJ Podcast - August 28, 2013 Category: General Medicine Authors: BMJ Group Source Type: podcasts
A New Era in the Treatment of PE and DVT
The results of this important trial fuel Dr. Samuel Goldhaber's excitement for new tools in the treatment of thrombosis. (Source: Medscape Cardiology Podcast)
Source: Medscape Cardiology Podcast - August 14, 2013 Category: Cardiology Authors: Medscape Source Type: podcasts
IVF and Thromboembolism: The Connection Is Clear
This F1000 commentary reports on a powerful study that shows beyond any doubt that in vitro fertilization poses an increased risk for venous thromboembolisms and pulmonary embolisms. (Source: Medscape ObGyn Podcast)
Source: Medscape ObGyn Podcast - May 24, 2013 Category: OBGYN Authors: Medscape Source Type: podcasts
#175: Apixaban approved: Now, which anticoagulant to use?; darbepoetin alfa disappoints in RED-HF; suspect thrombus with signs of early valve degeneration after TAVI; half of cardiology practices now integrated with hospitals
Apixaban approved: Now, which anticoagulant to use?; darbepoetin alfa disappoints in RED-HF; suspect thrombus with signs of early valve degeneration after TAVI; half of cardiology practices now integrated with hospitals (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - January 25, 2013 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
#129: ACCP thrombosis guidelines on aspirin in primary prevention; EMA on aliskiren, aprotinin, and orlistat; homocysteine saga: is gene analysis the final chapter?; FDA advisors recommend approval of obesity drug Qnexa; guideline-recommended HF therapies
ACCP thrombosis guidelines on aspirin in primary prevention; EMA on aliskiren, aprotinin, and orlistat; homocysteine saga: is gene analysis the final chapter?; FDA advisors recommend approval of obesity drug Qnexa; guideline-recommended HF therapies (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - February 24, 2012 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
Dalteparin vs Unfractionated Heparin in DVT Prophylaxis
Dr. Andy Shorr offers his perspective on a multicenter trial that explored whether dalteparin is superior to unfractionated heparin in preventing deep vein thrombosis among critically ill patients. (Source: Medscape Orthopaedics Podcast)
Source: Medscape Orthopaedics Podcast - April 15, 2011 Category: Orthopaedics Authors: Medscape Source Type: podcasts
The Lancet: March 5, 2010
Prevention of venous thrombosis after knee-replacement surgery (ADVANCE-2 study). (Source: Listen to The Lancet)
Source: Listen to The Lancet - March 6, 2010 Category: General Medicine Authors: The Lancet Source Type: podcasts
